National Marrow Donor Program Executive and Leadership Team

Amy Ronneberg, the Chief Executive Officer at National Marrow Donor Program, directs the overarching strategic vision for the organization. Ronneberg manages the expansion of the donor registry while ensuring operational excellence across all North American and international transplant networks. By aligning organizational goals with medical innovation, the Chief Executive Officer fosters partnerships that increase patient access to life-saving therapies. Ronneberg oversees the transition to the modernized brand identity, ensuring the mission remains central to all growth initiatives. This leadership role involves constant collaboration with the Board to maintain financial sustainability and regulatory compliance. Through rigorous oversight of internal processes, Amy Ronneberg secures the long-term viability of the registry. Ultimately, Ronneberg drives the mission to save lives by optimizing the efficiency of the entire transplant ecosystem, ensuring that every patient receives timely support regardless of geographic location or medical complexity.

Jeffrey Chell, the Chief Executive Officer Emeritus at National Marrow Donor Program, provides critical historical context and strategic guidance to the current leadership team. Chell supports the organization by advising on long-term policy development and maintaining key relationships within the global medical community. The Chief Executive Officer Emeritus facilitates the continuity of the mission, ensuring that foundational values remain integrated into modern operational strategies. By offering deep institutional knowledge, Chell assists in navigating complex regulatory landscapes and evolving healthcare standards. Jeffrey Chell contributes to the stability of the organization during periods of significant brand transformation and structural change. This advisory role involves mentoring senior staff and reinforcing the commitment to patient-centered care. Through consistent engagement with the executive suite, Chell ensures that the strategic direction remains aligned with the core purpose of facilitating life-saving transplants for patients worldwide, thereby preserving the legacy of the organization.

Katherine Heyerdahl, the Chief Financial Officer at National Marrow Donor Program, manages the fiscal health and resource allocation for the entire organization. Heyerdahl directs the budgeting process, financial reporting, and long-term investment strategies required to sustain the donor registry. By overseeing the financial infrastructure, the Chief Financial Officer ensures that capital is deployed effectively to support medical research and patient advocacy programs. Katherine Heyerdahl collaborates with other executives to align fiscal planning with the ambitious growth targets of the modernized brand. This leadership role involves rigorous monitoring of revenue streams and operational costs to maintain organizational agility. Through precise financial modeling and risk management, Heyerdahl secures the resources necessary for global expansion and technological upgrades. Ultimately, Heyerdahl drives the financial stability required to fulfill the mission, ensuring that the organization remains a reliable partner for patients and medical institutions across the international healthcare landscape.

Komal Khoja, the President at National Marrow Donor Program, executes the day-to-day operational strategy and ensures the alignment of all departments with the organizational mission. Khoja directs the implementation of programs that expand donor recruitment and enhance patient support services. By overseeing the cross-functional teams, the President ensures that the organization effectively manages the complexities of the transplant registry. Komal Khoja collaborates with the executive team to drive growth and improve the efficiency of service delivery across all regions. This leadership role involves managing internal communications and fostering a culture of innovation and accountability. Through the oversight of key operational initiatives, Khoja ensures that the organization remains responsive to the needs of patients and medical partners. Ultimately, Khoja drives the execution of the strategic plan, ensuring that the organization consistently meets its goals and maintains its position as a leader in the field of blood stem cell transplantation.

Jim Graham, the Chief Information Officer at National Marrow Donor Program, architects the digital infrastructure that powers the donor registry and patient matching systems. Graham directs the implementation of advanced data analytics and secure information platforms to streamline the transplant process. By overseeing the integration of complex health data, the Chief Information Officer ensures that medical professionals have real-time access to critical donor information. Jim Graham manages the cybersecurity protocols necessary to protect sensitive patient and donor records across all operational regions. This leadership role involves constant innovation in software development to improve the speed and accuracy of matching algorithms. Through the deployment of scalable technology solutions, Graham supports the organization's mission to increase transplant success rates. Ultimately, Graham drives the digital transformation of the registry, ensuring that the technological foundation remains robust, secure, and capable of meeting the evolving demands of the global medical community.

Rob Hanson, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer at National Marrow Donor Program, oversees the comprehensive security and technological integrity of the organization's data assets. Hanson directs the development of robust defense mechanisms to safeguard donor privacy and ensure compliance with international data protection regulations. By managing the intersection of technology and security, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer ensures that all digital platforms remain resilient against emerging threats. Rob Hanson collaborates with IT leadership to implement cutting-edge security protocols that protect the integrity of the registry. This leadership role involves continuous auditing of systems to maintain the highest standards of data governance. Through proactive risk mitigation, Hanson secures the trust of donors and patients alike, ensuring that the organization's technological operations remain secure, compliant, and fully aligned with the mission of saving lives.

Dennis Confer, the Chief Medical Officer at National Marrow Donor Program, leads the clinical strategy and medical standards that define the organization's transplant success. Confer directs the development of protocols for donor selection, medical evaluation, and patient safety. By overseeing the clinical research initiatives, the Chief Medical Officer ensures that the registry utilizes the most current scientific evidence to improve transplant outcomes. Dennis Confer collaborates with medical boards and international health organizations to establish best practices in blood stem cell transplantation. This leadership role involves constant monitoring of clinical performance metrics to identify areas for improvement in patient care. Through the application of rigorous medical expertise, Confer drives the quality assurance programs that maintain the integrity of the donor network. Ultimately, Confer ensures that every medical decision supports the mission of providing life-saving treatments, maintaining the highest standards of clinical excellence across all global operations.